Articles citing this paper
Preliminary Investigation of a Novel 18F Radiopharmaceutical for Imaging CB2 Receptors in a SOD Mouse Model
Giancarlo Pascali
A B C E , Daniele Panetta C , Mariarosaria De Simone C D , Silvia Burchielli C , Valentina Lucchesi D , Elena Sanguinetti C , Simone Zanoni B , Patricia Iozzo C , Giuseppe Saccomanni D , Clementina Manera D and Piero A. Salvadori C
+ Author Affiliations
- Author Affiliations
A Nuclear Medicine Department, Prince of Wales Hospital, Barker Street, Randwick, NSW 2031, Australia.
B School of Chemistry and Biological Resources Imaging Laboratory, University of New South Wales, High Street, Kensington, NSW 2052, Australia.
C Institute of Clinical Physiology, National Research Council (CNR), Via G. Moruzzi, Pisa 56124, Italy.
D Department of Pharmacy, University of Pisa, Via Bonanno Pisano, Pisa 56126, Italy.
E Corresponding author. Email: g.pascali@unsw.edu.au
Australian Journal of Chemistry 74(6) 443-452 https://doi.org/10.1071/CH20247
Submitted: 12 August 2020 Accepted: 21 December 2020 Published: 1 February 2021
5 articles found in Crossref database.
Cannabis and Cannabinoids
Duggan Peter J., Kassiou Michael
Australian Journal of Chemistry. 2021 74(6). p.367
Towards PET imaging of the dynamic phenotypes of microglia
Beaino Wissam,
Janssen Bieneke,
Vugts Danielle J,
de Vries Helga E, Windhorst Albert D
Clinical and Experimental Immunology. 2021 206(3). p.282
Structure-Based Design, Optimization, and Development of [18F]LU13: A Novel Radioligand for Cannabinoid Receptor Type 2 Imaging in the Brain with PET
Gündel Daniel,
Deuther-Conrad Winnie,
Ueberham Lea,
Kaur Sarandeep,
Otikova Elina,
Teodoro Rodrigo,
Toussaint Magali,
Lai Thu Hang,
Clauß Oliver,
Scheunemann Matthias,
Bormans Guy,
Bachmann Michael,
Kopka Klaus,
Brust Peter, Moldovan Rareş-Petru
Journal of Medicinal Chemistry. 2022 65(13). p.9034
PET imaging of neuroinflammation: any credible alternatives to TSPO yet?
Chauveau Fabien,
Winkeler Alexandra,
Chalon Sylvie,
Boutin Hervé, Becker Guillaume
Molecular Psychiatry. 2024
Synthesis, Structure–Activity Relationships, Radiofluorination, and Biological Evaluation of [18F]RM365, a Novel Radioligand for Imaging the Human Cannabinoid Receptor Type 2 (CB2R) in the Brain with PET
Teodoro Rodrigo,
Gündel Daniel,
Deuther-Conrad Winnie,
Kazimir Aleksandr,
Toussaint Magali,
Wenzel Barbara,
Bormans Guy,
Hey-Hawkins Evamarie,
Kopka Klaus,
Brust Peter, Moldovan Rareş-Petru
Journal of Medicinal Chemistry. 2023 66(20). p.13991
